Bas L. van der Hoeven

Author

Also Known As

B Hoeven, B L van der Hoeven, B. L. Van Der Hoeven, B.L. van der Hoeven, Bas L van der Hoeven, Bas L. van der Hoeven, Bas Leendert van der Hoeven, Bas van der Hoeven

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Netherlands Heart Institute Medisch Centrum Leeuwarden Medisch Centrum Alkmaar Erasmus MC

About

Bas L. van der Hoeven is an author at Leiden University Medical Center specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.1K
2	Emergency Medicine	10	11	731
3	Public Health	7	7	591
4	Epidemiology	1	1	62
5	Gender Studies	1	1	62

Bas L. van der Hoeven

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Diagnostic Accuracy of 64-Slice Multislice Computed Tomography in the Noninvasive Evaluation of Significant Coronary Artery Disease Joanne D. Schuijf, Gabija Pundziūtė, J. Wouter Jukema, The American Journal of Cardiology Vascular ImageMedical ImagingCardiovascular DiseaseAtherosclerosisMedicine	2006	232
Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: 9-Month Angiographic and Intravascular Ultrasound Results and 12-Month Clinical Outcome Bas L. van der Hoeven, Su‐San Liem, J. Wouter Jukema, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionIntravascular Ultrasound ResultsCardiovascular Disease9-Month Angiographic	2008	146
Left Ventricular Dyssynchrony Acutely After Myocardial Infarction Predicts Left Ventricular Remodeling Sjoerd A. Mollema, Su San Liem, Matthew S. Suffoletto, Journal of the American College of Cardiology CardiomyopathyHeart FailureCardiovascular DiseaseMedicineCardiology	2007	120
Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention Matthijs A. Velders, Helèn Boden, Sjoerd H. Hofma, The American Journal of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseMedicineCancer TreatedOutcomes Research	2013	120
Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction Bas L. van der Hoeven, Su‐San Liem, Jouke Dijkstra, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionBare-metal Stent ImplantationStent MalappositionCardiovascular DiseaseCoronary Unit	2008	84
CCL3 (MIP-1α) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events Saskia C.A. de Jager, Adriaan O. Kraaijeveld, Robert W Grauss, Journal of Molecular and Cellular Cardiology InflammationStrong Prognostic PowerCardiovascular DiseaseMyocardial InfarctionImmunology	2008	70
Influence of Gender on Ischemic Times and Outcomes After ST-Elevation Myocardial Infarction Matthijs A. Velders, Helèn Boden, Adrianus J. van Boven, The American Journal of Cardiology Percutaneous Coronary InterventionGender IdentityCardiovascular DiseaseGender StudiesIschemic Times	2012	62
Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study) Jael Z. Atary, Bas L. van der Hoeven, Su San Liem, The American Journal of Cardiology Percutaneous Coronary InterventionIntervention StudyCardiovascular DiseaseCoronary Artery DiseaseThree-year Outcome	2010	51
Peak and Fixed-Time High-Sensitive Troponin for Prediction of Infarct Size, Impaired Left Ventricular Function, and Adverse Outcomes in Patients With First ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention Helèn Boden, Tarek Ahmed, Matthijs A. Velders, The American Journal of Cardiology Percutaneous Coronary InterventionHeart FailureFixed-time High-sensitive TroponinCardiovascular DiseaseMyocardial Infarction	2013	48
Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial Helèn Boden, Bas L. van der Hoeven, Su‐San Liem, EuroIntervention	2012	35

Page 1